TRIP4 and breast cancer: Moreover, the expression of the ASC1 mutant, an UFMylation defective form, or knockout of the UBA5 inhibited tumor growth, suggesting that the UFMylation of ASC1 is important for the transactivation of ERα and thus breast cancer development [41].